Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty. [PDF]
Huang C +7 more
europepmc +1 more source
Engineering megakaryocytes with oncolytic viruses for <i>in situ</i> generation of therapeutic platelets. [PDF]
Yang Y, Gu Z, Yu J.
europepmc +1 more source
Hematopoietic JAK2V617F mutation-induced reprogramming of blood and bone marrow megakaryocytes. [PDF]
Lu S +5 more
europepmc +1 more source
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 919-920, October 2026.
Afshin Shameli, Russell K. Dorer
wiley +1 more source
Synergistic effects of luspatercept and cyclosporine A in lower-risk myelodysplastic syndrome with red cell aplasia: Two case insights. [PDF]
Jo T +6 more
europepmc +1 more source
Marked Bone Marrow Eosinophilia Post‐Azacitidine + Ivosidenib Treatment for Acute Myeloid Leukemia
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 921-923, October 2026.
Christopher Liwski +2 more
wiley +1 more source
Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies. [PDF]
Martino M +4 more
europepmc +1 more source
Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears. [PDF]
Eckardt JN +11 more
europepmc +1 more source
Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 931-933, October 2026.
Paige Muir +3 more
wiley +1 more source
JARID2 inhibition reprograms human hematopoietic progenitor cells to enhance bone marrow transplantation. [PDF]
Han W +15 more
europepmc +1 more source

